GlassScriptPhysician profile
Sarah Jane Stanescu
NPI 1811330707
$9,750.10
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.96 · 2020: $17.14 · 2021: $9,318 · 2022: $104 · 2023: $177 · 2024: $106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $282.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,285.54 | 2021 | |
| Abbvie INC. | $98.83 | 2019-2023 | Liletta |
| Sumitomo Pharma America, INC. | $68.10 | 2023-2024 | Myfembree, Gemtesa |
| Shield Therapeutics INC | $67.56 | 2023 | Accrufer |
| Organon LLC | $57.42 | 2022-2024 | |
| Optumhealth Care Solutions, LLC | $27.14 | 2024 | Vivify Health Care Team Portal 001, Eitan Medical |
| Mayne Pharma Commercial LLC | $24.41 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $20.44 | 2024 | |
| Exeltis, USA INC. | $20.37 | 2023 | Slynd |
| Myovant Sciences INC. | $16.24 | 2022 | |
| Astellas Pharma US INC | $16.02 | 2023 | Myrbetriq |
| Mylan Pharmaceuticals INC. | $15.82 | 2022 | |
| Merck Sharp & Dohme LLC | $11.30 | 2021 | |
| Allergan, INC. | $10.81 | 2019 | |
| Aspira Women'S Health INC | $10.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Stanescu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.